2-Fluoro-3-iodo-5-methylpyridine

We are 2-Fluoro-3-iodo-5-methylpyridine CAS:153034-78-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  2-Fluoro-3-iodo-5-methylpyridine
CAS.NO: 153034-78-7
Synonyms:2-fluoro-3-iodo-5-methyl-pyridine;
2-fluoro-3-iodo-5-picoline;
2-fluoro-3-iodo-5-methylpyridine;
Molecular Formula:C6H5FIN
Molecular Weight:237.01300
 
Physical and Chemical Properties:
Density: 1.182 g/cm3
Melting point:/
Boiling point: 201.7ºC at 760mmHg
Flash point:91.1ºC
Index of Refraction: 1.587
 
Specification:
Appearance: White Crystalline Powder
Purity:≥99.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry.
Application:    used to Pharmaceutical intermediate

2-Fluoro-3-iodo-5-methylpyridine


Related News: The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.Triphenylmethanol CAS:76-84-6 Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.2 – [(1R) -3- (Diisopropilamino) -1-fenilpropil] -4- (hidroximetil) fenol (2E) -2-butenodioato (1: 1) CAS:380636-50-0 Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.4,5-DIFLUORO-2-METHYLBENZOIC ACID CAS:183237-86-7 The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.

Related Products
Product Name
2-Hydroxy-5-bromopyridine View Details
1,2-Octanediol View Details
4,4-Difluorocyclohexanecarboxylic Acid View Details
Calcitonin salmon manufacturer 1-Benzhydrylazetidin-3-amine manufacturer 5-Chloro-2-fluoropyridine manufacturer 4-Aminopiperidine manufacturer L-Leucyl-D-valine manufacturer